Market Overview The immunomodulators market is revolutionizing oncology through cancer immunotherapy checkpoint inhibitors unleashing anti-tumor immune responses with durable remission potential. The Immunomodulators Market is projected to grow through 2030, driven by PD-1/PD-L1 inhibitor expansion, CTLA-4 combination strategies, and novel checkpoint target discovery supporting curative intent...